High Flow Nasal Cannulamarket Scope And Analysis

  • Report Code : TIPMD00002292
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

High Flow Nasal Cannula Market Scope, Growth, Size and Share by 2031

Buy Now


High Flow Nasal Cannula Market Report Scope

Report Attribute Details
Market size in 2023 US$ 7.2 Billion
Market Size by 2031 US$ 18.5 Billion
Global CAGR (2023 - 2031) 12.5%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Component
  • Air Oxygen Blender
  • Nasal Cannula
  • Heated Inspiratory Circuit
  • Active Humidifier
By Application
  • Bronchiectasis
  • Acute Respiratory Failure
  • Acute Heart Failure
  • Chronic Obstructive Pulmonary Disease
By End User
  • Ambulatory Care Centers
  • Hospital
  • Long-Term Care Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Fisher Paykel Healthcare Limited
  • ResMed
  • Great Group Medical Co Ltd
  • Salter Labs
  • TNI Medical Ag
  • Mek Ics Co Ltd
  • Flexicare Medical Limited
  • Vapotherm
  • Teleflex Incorporated
  • Hamilton Medical
  • High Flow Nasal Cannula Market News and Recent Developments

    The high flow nasal cannula market is evaluated by gathering qualitative and quantitative data from primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the high flow nasal cannula market are listed below:

    • Masimo announced the U.S. introduction of softFlow, innovative pulmonary care therapy which provides nasal high-flow warmed and humidified respiratory gases to spontaneously breathing patients. (Source: Masimo, Press Release, April 2021)
    • Fisher & Paykel Healthcare Corporation Limited announced that it has released the Airvo 3 high flow system. This device incorporates the company’s OptiO2™ closed-loop system for targeted oxygen delivery, which helps to ensure the patient is provided the right level of oxygen. Other new features include an integrated battery, a large touchscreen interface, expanded settings for pediatric and neonatal patients, and an increased maximum flow rate of 70 litres per minute compared to 60 litres per minute on the Airvo 2. (Source: Fisher & Paykel Healthcare Limited, Press Release, May 2022)

    High Flow Nasal Cannula Market Report Coverage and Deliverables

    The “High Flow Nasal Cannula Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • High Flow Nasal Cannula market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • High Flow Nasal Cannula market trends, as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • High Flow Nasal Cannula market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the High Flow Nasal Cannula market
    • Detailed company profiles